Executive interview – ASIT Biotech

Executive interview – ASIT Biotech

In this interview Michel Baijot, CEO of Asit Biotech, discusses what is unique about the company and what newsflow investors can expect from ASIT in the second half of 2019.


You may also be interested in these:

TMT

IP Group - executive interview

Investment Companies

Oakley Capital Investments – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free